The Atopic March. A Literature Review
Keywords:Atopic dermatitis, asthma, allergy, atopy, Th2 response, atopic march
The atopic march is defined as the progression of atopic diseases, generally during childhood, such as atopic dermatitis, asthma, allergic rhinitis and food allergies. The main risk factors for developing these atopic diseases include genetics, aeroallergens, food allergens, latefood introduction to the infant, and living in developing countries. The immunologic contributors to this problem include the Th2 response, epigenetics, and lack of certain factors like thymic stromal lymphopoietin (TSLP) and filaggrin. As a whole, the therapeutic approach has been changing during recent years because of the discovery of new factors involved in this problem. This article explains the definition of atopic march, the immunological pathway, clinical features, epidemiology and therapeutic approaches to create a context for the broader understanding of this important condition.
2. Demehri S, Yockey LJ, Visness CM, Jaffee KF, Turkoz A, Wood RA, et al. Circu¬lating TSLP associates with decreased wheezing in non-atopic preschool chil¬dren: Data from the URECA birth cohort. Clin Exp Allergy. 2014 Jun;44(6):851-7.
3. Begin P, Nadeau KC. Epigenetic regulation of asthma and allergic disease. Allergy Asthma Clin Immunol. 2014 May 28;10(1):27.
4. Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy. 2014 Jan;69(1):17- 27.
5. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Loannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009 Jul 21;6(7):e1000100.
6. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigen¬mann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006 Jul;118(1):152-69.
7. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. Allergy Clin Immunol. 2003 Dec;112(6 Suppl):S118-27.
8. Spergel JM. Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol. 2005 Feb;5(1):17-21.
9. Marenholz I, Nickel R, Ruschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, et al. Filaggrin loss-of-function mutations predispose to phenotypes in¬volved in the atopic march. J Allergy Clin Immunol. 2006 Oct;118(4):866-71.
10. Zheng T, Yu J, Oh MH, Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011 Apr;3(2):67-73.
11. He R, Geha RS. Thymic stromal lymphopoietin. Ann N Y Acad Sci. 2010 Jan;1183:13-24.
12. Takai T, Chen X, Xie Y, Vu AT, Le TA, Kinoshita H, et al. TSLP Expression Induced via Toll-Like Receptor Pathways in Human Keratinocytes. Methods Enzymol. 2014;535:371-87.
13. Zhang Z, Hener P, Frossard N, Kato S, Metzger D, Li M, et al. Thymic stro¬mal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1536-41.
14. Auriemma M, Vianale G, Amerio P, Reale M. Cytokines and T cells in atopic dermatitis. Eur Cytokine Netw. 2013 Mar;24(1):37-44.
15. Li M. Skin TSLP and “atopic march”: What do we learn from mouse mo¬dels?. Rev Fr Allergol. 2012 Jun;52(4):324-6.
16. Hatzler L, Hofmaier S, Papadopoulos NG. Allergic airway diseases in child¬hood - marching from epidemiology to novel concepts of prevention. Pediatr Allergy Immunol. 2012 Nov;23(7):616-22.
17. Kumar R, Gupta N, Goel N. Correlation of atopy and FeNO in allergic rhi¬nitis: an Indian study. Indian J Chest Dis Allied Sci. 2013 Apr-Jun;55(2):79-83.
18. Min YG. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2010 Apr;2(2):65-76.
19. Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005 Jun;35(6):728-32.
20. Liu CY, Zhang Y, Han DM, Zhang L. Evaluation of serum specific IgE for the diagnosis of allergic rhinitis with multi-allergens. Chin Med J (Engl). 2010 Oct;123(20):2836-41.
21. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma up¬date: allergen immunotherapy. J Allergy Clin Immunol. 2007 Apr;119(4):881-91
22. Schroeder A, Kumar R, Pongracic JA, Sullivan CL, Caruso DM, Costello J, et al. Food allergy is associated with an increased risk of asthma. Clin Exp Allergy. 2009 Feb;39(2):261-70.
23. Noh G, Lee JH. Revision of immunopathogenesis and laboratory inter¬pretation
for food allergy in atopic dermatitis. Inflamm Allergy Drug Targets. 2012 Feb;11(1):20-35.
24. Luo J, Li Y, Gong R. The mechanism of atopic march may be the 'social' event of cells and molecules (Review). Int J Mol Med. 2010 Dec;26(6):779-85.
25. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000 Nov;30(11):1604-10.
26. MacDonald TT, Di Sabatino A. The immunologic basis for gastrointestinal food allergy. Curr Opin Gastroenterol. 2009 Nov;25(6):521-6.
27. Nwaru BI, Takkinen HM, Niemela O, Kaila M, Erkkola M, Ahonen S, et al. Timing of infant feeding in relation to childhood asthma and allergic disea¬ses. J Allergy Clin Immunol. 2013 Jan;131(1):78-86.
28. Szajewska H. The prevention of food allergy in children. Curr Opin Clin Nutr Metab Care. 2013 May;16(3):346-50.
29. Barberio G, Pajno GB, Vita D, Caminiti L, Canonica GW, Passalacqua G. Does a 'reverse' atopic march exist?. Allergy. 2008 Dec;63(12):1630-2.
30. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010 Aug;105(2):99-106; quiz 107-9, 117.
31. Kijima A, Murota H, Takahashi A, Arase N, Yang L, Nishioka M, et al. Preva¬lence and impact of past history of food allergy in atopic dermatitis. Allergol Int. 2013 Mar;62(1):105-12.
32. Shen CY, Lin MC, Lin HK, Lin CH, Fu LS, Fu YC. The natural course of ecze¬ma from birth to age 7 years and the association with asthma and allergic rhinitis: a population-based birth cohort study. Allergy Asthma Proc. 2013 Jan-Feb;34(1):78-83.
33. Lowe AJ, Carlin JB, Bennett CM, Hosking CS, Abramson MJ, Hill DJ, et al. Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol. 2008 May;121(5):1190-5.
34. Schachter LM, Peat JK, Salome CM. Asthma and atopy in overweight chil¬dren. Thorax. 2003 Dec;58(12):1031-5.
35. American College of Allergy, Asthma, & Immunology. Food allergy: a prac¬tice parameter. Ann Allergy Asthma Immunol. 2006 Mar;96(3 Suppl 2):S1-68.
36. Allen KJ, Dharmage SC. The role of food allergy in the atopic march. Clin Exp Allergy. 2010 Oct;40(10):1439-41
37. Spergel JM. Epidemiology of atopic dermatitis and atopic march in chil¬dren. Immunol Allergy Clin North Am. 2010 Aug;30(3):269-80.
38. Van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol. 2007 Sep;120(3):565-9.
39. Saunes M, Oien T, Dotterud CK, Romundstad PR, Storro O, Holmen TL, et al. Early eczema and the risk of childhood asthma: a prospective, popula¬tion-based study. BMC Pediatr. 2012 Oct 24;12:168.
40. Dennis R, Caraballo L, García E, Rojas M, Rondon M, Pérez A, et al. Pre¬valence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional study. BMC Pulm Med. 2012 Jul 13;12:17
41. Hwang CY, Chen YJ, Lin MW, Chen TJ, Chu SY, Chen CC, et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta Derm Venereol. 2010 Nov;90(6):589-94.
42. Waked M, Salameh P. Asthma, allergic rhinitis and eczema in 5-12-year-old school children across Lebanon. Public Health. 2008 Sep;122(9):965-73.
43. Gordon BR. The allergic march: can we prevent allergies and asthma?. Otolaryngol Clin North Am. 2011 Jun;44(3):765-77, xi.
44. Tan RA, Corren J. The relationship of rhinitis and asthma, sinusitis, food allergy, and eczema. Immunol Allergy Clin North Am. 2011 Aug;31(3):481-91.
45. Patrizi A, Pileri A, Bellini F, Raone B, Neri I, Ricci G. Atopic Dermatitis and the Atopic March: What Is New?. J Allergy (Cairo). 2011;2011:279425.
46. Bochner BS, Rothenberg ME, Boyce JA, Finkelman F. Advances in mecha¬nisms of allergy and clinical immunology in 2012. J Allergy Clin Immunol. 2013 Mar;131(3):661-7.
47. Van Bever HP, Samuel ST, Lee BW. Halting the allergic march. World Allergy Organ J. 2008 Apr;1(4):57-62.
48. Rinne M, Kalliomaki M, Arvilommi H, Salminen S, Isolauri E. Effect of
probiotics and breastfeeding on the bifidobacterium and lactobacillus/ enterococcus microbiota and humoral immune responses. J Pediatr. 2005 Aug;147(2):186-91.
49. Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, He¬patology, and Nutrition. Probiotics and Prebiotics in Pediatrics. Pediatrics. 2010 Dec;126(6):1217-31.
50. Vitaliti G, Pavone P, Guglielmo F, Spataro G, Falsaperla R. The immuno¬modulatory effect of probiotics beyond atopy: an update. J Asthma. 2014
51. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002 Jan;109(1):119-21.
52. Giudice MM, Rocco A, Capristo C. Probiotics in the atopic march: highli¬ghts and new insights. Dig Liver Dis. 2006 Dec;38 Suppl 2:S288-90.
53. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergy. Cochra¬ne Database Syst Rev. 2013 Mar 28;3:CD006474.
How to Cite
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to firstname.lastname@example.org
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to email@example.com